These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8499625)

  • 1. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura.
    Fujisawa K; Tani P; Piro L; McMillan R
    Blood; 1993 Jun; 81(11):2872-7. PubMed ID: 8499625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
    Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
    Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
    Fabrizio F; Luzzatto G; Ramon R; Randi ML; De Silvestro G; Girolami A
    Haematologica; 2000 Aug; 85(8):888-90. PubMed ID: 10942951
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Saulsbury FT; Bringelsen KA
    Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol for the treatment of idiopathic thrombocytopenic purpura.
    Ahn YS; Harrington WJ; Simon SR; Mylvaganam R; Pall LM; So AG
    N Engl J Med; 1983 Jun; 308(23):1396-9. PubMed ID: 6682484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A; Konopka L; Maślanka K
    Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of adult idiopathic thrombocytopenic purpura.
    Cines DB; McMillan R
    Annu Rev Med; 2005; 56():425-42. PubMed ID: 15660520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids.
    Kotlarek-Haus S; Podolak-Dawidziak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):768-76. PubMed ID: 2453406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and treatment of idiopathic thrombocytopenic purpura].
    Dan K
    Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):319-26. PubMed ID: 8937118
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura.
    Burns TR; Saleem A
    Am J Med; 1983 Dec; 75(6):1001-7. PubMed ID: 6685977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].
    Böcher A; Hagmann FG; Kreiter H
    Med Klin (Munich); 1998 Dec; 93(12):707-18. PubMed ID: 10024838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of platelet recovery in ITP associated with therapy.
    Pang SJ; Lazarus AH
    Ann Hematol; 2010 Jul; 89 Suppl 1():31-5. PubMed ID: 20179926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.